Manganese in human parenteral nutrition: Considerations for toxicity and biomonitoring

NeuroToxicology

Volumn 43, Issue , 2014, Pages 36-45

  Santos, Dinamene ^a   Batoreu, Camila ^a   Mateus, Luisa ^a   Marreilha dos Santos, A P ^a   Aschner, Michael ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomonitoring; Manganese; Neurotoxicity; Parenteral nutrition

Indexed keywords

BIOLOGICAL MARKER; MANGANESE;

ARTICLE; BIOAVAILABILITY; BIOLOGICAL MONITORING; BLOOD LEVEL; BODY FLUID; BRAIN FUNCTION; COMORBIDITY; DATA ANALYSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; HUMAN; HYPERMAGNESEMIA; IMAGE ANALYSIS; NEUROIMAGING; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT; RISK FACTOR; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; CATECHOLAMINERGIC SYSTEM; CLINICAL EVALUATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; HYPERMANGANESEMIA; MANGANESE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL ASSESSMENT; PATIENT SAFETY; TREATMENT DURATION; COMPLICATION; ENVIRONMENTAL MONITORING; FEMALE; INTOXICATION; MALE; NEUROTOXICITY SYNDROMES; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; MANGANESE; MANGANESE POISONING; NEUROTOXICITY SYNDROMES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84905913822     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.10.003     Document Type: Article

References (152)

1. Abrams E., Lassiter J.W., Miller W.J., Neathery M.W., Gentry R.P., Scarth R.D. Absorption as a factor in manganese homeostasis. J Anim Sci 1976, 42:630-636.
2. Ai L.B., Chua L.H., New A.L., Lee B.L., Liu Y.M., Chia S.E., et al. Urinary homovanillic acid (HVA) and vanillymandelic acid (VMA) in workers exposed to manganese dust. Biol Trace Elem Res 1998, 64:89-99.
3. Alessio L., Apostoli P., Ferioli A., Lombardi S. Interference of manganese on neuroendocrinal system in exposed workers Preliminary report. Biol Trace Elem Res 1989, 21:249-253.
4. Altindag Z.Z., Baydar T., Engin A.B., Sahin G. Effects of the metals on dihydropteridine reductase activity. Toxicol In Vitro 2003, 17:533-537.
5. Alves G., Thiebot J., Tracqui A., Delangre T., Guedon C., Lerebours E. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. J Parenter Enter Nutr 1997, 21:41-45.
6. AMA Guidelines for essential trace element preparations for parenteral use. JAMA 1979, 241:2051-2054.
7. Amorim L. Os biomarcadores e a sua aplicação na avaliação da exposição aos agentes químicos ambientais. Rev Bras Epidemiol 2003, 6:158-170.
8. Anderson J.G., Cooney P.T., Erikson K.M. Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol 2007, 23:179-184.
9. Angsten G., Finkel Y., Lucas S., Kassa A.M., Paulsson M., Lilja H.E. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with omega-6/9 lipid emulsions. J Parenter Enter Nutr 2012, 36:587-595.
10. Apostoli P., Lucchini R., Alessio L. Are current biomarkers suitable for the assessment of manganese exposure in individual workers. Am J Ind Med 2000, 37:283-290.
11. Aschner M., Aschner J.L. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev 1991, 15:333-340.
12. Aschner J., Aschner M. Nutritional aspects of Mn homeostasis. Mol Aspects Med 2005, 353-362.
13. Aschner M., Erikson K.M., Dorman D.C. Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol 2005, 35:1-32.
14. Atkinson A.J., DeGruttola V.G., DeMets D.L., Downing G.J., Hoth D.F., Oates J.A., et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
15. ATSDR Toxicological Profile for Manganese. Atlanta Georgia: US Department of Health and Human Services. Agency for Toxic Substances and Disease Registry 2000, 1-466.
16. Au C., Benedetto A., Aschner M. Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology 2008, 29:569-576.
17. Bagga P., Patel A.B. Regional cerebral metabolism in mouse under chronic manganese exposure: implications for manganism. Neurochem Int 2012, 60:177-185.
18. Bai S.P., Lu L., Luo X.G., Liu B. Kinetics of manganese absorption in ligated small intestinal segments of broilers. Poult Sci 2008, 87:2596-2604.
19. Banta R.G., Markesbery W.R. Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology 1977, 27:213-216.
20. Bertinchamps A.J., Miller S.T., Cotzias G.C. Interdependence of routes excreting manganese. Am J Physiol 1966, 211:217-224.
21. Bertinet D.B., Tinivella M., Balzola F.A., de Francesco A., Davini O., Rizzo L., et al. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. J Parenter Enter Nutr 2000, 24:223-227.
22. Bowler R.M., Gysens S., Diamond E., Booty A., Hartney C., Roels H.A. Neuropsychological sequelae of exposure to welding fumes in a group of occupationally exposed men. Int J Hyg Environ Health 2003, 206:517-529.
23. Bowler R.M., Nakagawa S., Drezgic M., Roels H.A., Park R.M., Diamond E., et al. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology 2007, 28:298-311.
24. Buchet J.P., Lauwerys R., Roels H., De Vos C. Determination of manganese in blood and urine by flameless atomic absorption spectrophotometry. Clin Chim Acta 1976, 73:481-486.
25. Buchman A.L., Howard L.J., Guenter P., Nishikawa R.A., Compher C.W., Tappenden K.A. Micronutrients in parenteral nutrition: too little or too much? The past, present, and recommendations for the future. Gastroenterology 2009, 137:S1-S6.
26. Butler I.J., Koslow S.H., Krumholz A., Holtzman N.A., Kaufman S. A disorder of biogenic amines in dihydropteridine reductase deficiency. Ann Neurol 1978, 3:224-230.
27. Calabresi P., Ammassari-Teule M., Gubellini P., Sancesario G., Morello M., Centonze D., et al. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiol Dis 2001, 8:419-432.
28. Chandra S.V., Shukla G.S. Role of iron deficiency in inducing susceptibility to manganese toxicity. Arch Toxicol 1976, 35:319-323.
29. Chandra S.V., Malhotra K.M., Shukla G.S. GABAergic neurochemistry in manganese exposed rats. Acta Pharmacol Toxicol (Copenh) 1982, 51:456-458.
30. Chang A., Shin S.H. Relationships between dopamine-induced changes in cytosolic free calcium concentration ([Ca2+]i) and rate of prolactin secretion. Elevated [Ca2+]i does not indicate prolactin release. Endocrine 1997, 7:343-349.
31. Chua A.C., Morgan E.H. Manganese metabolism is impaired in the Belgrade laboratory rat. J Comp Physiol B 1997, 167:361-369.
32. Chua A.C., Stonell L.M., Savigni D.L., Morgan E.H. Mechanisms of manganese transport in rabbit erythroid cells. J Physiol 1996, 493:99-112.
33. Costa L.G. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ Health Perspect 1996, 104(Suppl 1):55S-67S.
34. Cotzias G.C., Horiuchi K., Fuenzalida S., Mena I. Chronic manganese poisoning. Clearance of tissue manganese concentrations with persistance of the neurological picture. Neurology 1968, 18:376-382.
35. Crossgrove J., Yokel R.A. Manganese distribution across the blood-brain barrier. III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 2004, 25:451-460.
36. Davidsson L., Cederblad A., Lonnerdal B., Sandstrom B. Manganese absorption from human milk, cow's milk, and infant formulas in humans. Am J Dis Child 1989, 143:823-827.
37. Davis C.D., Greger J.L. Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am J Clin Nutr 1992, 55:747-752.
38. Davis C.D., Zech L., Greger J.L. Manganese metabolism in rats: an improved methodology for assessing gut endogenous losses. Proc Soc Exp Biol Med 1993, 202:103-108.
39. Dickerson R.N. Manganese intoxication and parenteral nutrition. Nutrition 2001, 17:689-693.
40. Doisy E.A. Effects of deficiency in manganese upon plasma levels of clotting proteins and cholesterol in man. Trace element metabolism in animals 1974, 668-670. University Park Press, Baltimore. W.G. Hoekstra, J.W. Suttie, H.E. Ganther, W. Mertz (Eds.).
41. Dudrick S.J., Wilmore D.W., Vars H., Rhoads J.E. Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surgery 1968, 64:134-142.
42. Dydak U., Jiang Y.M., Long L.L., Zhu H., Chen J., Li W.M., et al. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect 2011, 119:219-224.
43. ECETOC Recognition of, and differentiation between, adverse and non-adverse effects in toxicology studies - Technical Report 85 2002, 1-56. European Centre for Ecotoxicology and Toxicology of Chemicals.
44. Eisenhofer G., Kopin I.J., Goldstein D.S. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004, 56:331-349.
45. Ejima A., Imamura T., Nakamura S., Saito H., Matsumoto K., Momono S. Manganese intoxication during total parenteral nutrition. Lancet 1992, 339:426.
46. Emara A.M., el-Ghawabi S.H., Madkour O.I., el-Samra G.H. Chronic manganese poisoning in the dry battery industry. Br J Ind Med 1971, 28:78-82.
47. Erikson K.M., Aschner M. Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology 2006, 27:125-130.
48. Erikson K.M., Shihabi Z.K., Aschner J.L., Aschner M. Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res 2002, 87:143-156.
49. Erikson K.M., John C.E., Jones S.R., Aschner M. Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter. Environ Toxicol Pharmacol 2005, 20:390-394.
50. Fallon E.M., Le H.D., Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant 2010, 15:334-340.
51. Fell J.M., Reynolds A.P., Meadows N., Khan K., Long S.G., Quaghebeur G., et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 1996, 347:1218-1221.
52. Finkelstein Y., Zhang N., Fitsanakis V.A., Avison M.J., Gore J.C., Aschner M. Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study. Isr Med Assoc J 2008, 10:793-798.
53. Finley J.W., Davis C.D. Manganese deficiency and toxicity: are high or low dietary amounts of manganese cause for concern. Biofactors 1999, 10:15-24.
54. Fitsanakis V.A., Au C., Erikson K.M., Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int 2006, 48:426-433.
55. Fitsanakis V.A., Zhang N., Anderson J.G., Erikson K.M., Avison M.J., Gore J.C., et al. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 2008, 103:116-124.
56. Fitzgerald K., Mikalunas V., Rubin H., McCarthey R., Vanagunas A., Craig R.M. Hypermanganesemia in patients receiving total parenteral nutrition. J Parenter Enter Nutr 1999, 23:333-336.
57. Frankel D. Supplementation of trace elements in parenteral nutrition: rationale and recommendations. Nutr Res 1993, 13:583-596.
58. Freeland-Graves J.H., Behmardi F., Bales C.W., Dougherty V., Lin P.H., Crosby J.B., et al. Metabolic balance of manganese in young men consuming diets containing five levels of dietary manganese. J Nutr 1988, 118:764-773.
59. Friedman B.J., Freeland-Graves J.H., Bales C.W., Behmardi F., Shorey-Kutschke R.L., Willis R.A., et al. Manganese balance and clinical observations in young men fed a manganese-deficient diet. J Nutr 1987, 117:133-143.
60. Garcia S.J., Gellein K., Syversen T., Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci 2006, 92:516-525.
61. Garcia-Aranda J.A., Wapnir R.A., Lifshitz F. In vivo intestinal absorption of manganese in the rat. J Nutr 1983, 113:2601-2607.
62. Gil F., Pla A. Biomarkers as biological indicators of xenobiotic exposure. J Appl Toxicol 2001, 21:245-255.
63. Goldhaber S.B. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 2003, 38:232-242.
64. Graham M.F., Tavill A.S., Halpin T.C., Louis L.N. Inhibition of bile flow in the isolated perfused rat liver by a synthetic parenteral amino acid mixture: associated net amino acid fluxes. Hepatology 1984, 4:69-73.
65. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
66. Greene H.L., Hambidge K.M., Schanler R., Tsang R.C. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the subcommittee on pediatric parenteral nutrient requirements from the committee on clinical practice issues of the american society for clinical nutrition. Am J Clin Nutr 1988, 48:1324-1342.
67. Greger J.L. Dietary standards for manganese: overlap between nutritional and toxicological studies. J Nutr 1998, 128:368S-371S.
68. Greger J.L. Nutrition versus toxicology of manganese in humans: evaluation of potential biomarkers. Neurotoxicology 1999, 20:205-212.
69. Greger J.L., Davis C.D., Suttie J.W., Lyle B.J. Intake, serum concentrations, and urinary excretion of manganese by adult males. Am J Clin Nutr 1990, 51:457-461.
70. Gropper S., Smith J. Advanced nutrition and human metabolism 2013, Yolanda Cossio, Belmont. 6th ed.
71. Gunshin H., Allerson C.R., Polycarpou-Schwarz M., Rofts A., Rogers J.T., Kishi F., et al. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett 2001, 509:309-316.
72. Gwiazda R.H., Lee D., Sheridan J., Smith D.R. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology 2002, 23:69-76.
73. Hagenfeldt K., Plantin L.O., Diczfalusy E. Trace elements in the human endometrium. 2. Zinc, copper and manganese levels in the endometrium, cervical mucus and plasma. Acta Endocrinol (Copenh) 1973, 72:115-126.
74. Hambidge K.M., Sokol R.J., Fidanza S.J., Goodall M.A. Plasma manganese concentrations in infants and children receiving parenteral nutrition. J Parenter Enter Nutr 1989, 13:168-171.
75. Hardy G. Manganese in parenteral nutrition: who, when, and why should we supplement. Gastroenterology 2009, 137:S29-S35.
76. Hardy I.J., Gillanders L., Hardy G. Is manganese an essential supplement for parenteral nutrition. Curr Opin Clin Nutr Metab Care 2008, 11:289-296.
77. Heilig E., Molina R., Donaghey T., Brain J.D., Wessling-Resnick M. Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats. Am J Physiol Lung Cell Mol Physiol 2005, 288:L887-L893.
78. Howard L., Ashley C., Lyon D., Shenkin A. Autopsy tissue trace elements in 8 long-term parenteral nutrition patients who received the current U.S. Food and Drug Administration formulation. J Parenter Enter Nutr 2007, 31:388-396.
79. Hsieh C.T., Liang J.S., Peng S.S., Lee W.T. Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatr Neurol 2007, 36:181-183.
80. Hurley L.S. Teratogenic aspects of manganese, zinc, and copper nutrition. Physiol Rev 1981, 61:249-295.
81. Iinuma Y., Kubota M., Uchiyama M., Yagi M., Kanada S., Yamazaki S., et al. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition. Pediatr Surg Int 2003, 19:268-272.
82. Ikeda S., Sera Y., Yoshida M., Ohshiro H., Uchino S., Oka Y., et al. Manganese deposits in patients with biliary atresia after hepatic porto-enterostomy. J Pediatr Surg 2000, 35:450-453.
83. Iregren A. Using psychological tests for the early detection of neurotoxic effects of low level manganese exposure. Neurotoxicology 1994, 15:671-677.
84. Iyengar V., Woittiez J. Trace elements in human clinical specimens: evaluation of literature data to identify reference values. Clin Chem 1988, 34:474-481.
85. Jetton M.M., Sullivan J.F., Burch R.E. Trace element contamination of intravenous solutions. Arch Intern Med 1976, 136:782-784.
86. Jones M.O., Pierro A., Hammond P., Nunn A., Lloyd D.A. Glucose utilization in the surgical newborn infant receiving total parenteral nutrition. J Pediatr Surg 1993, 28:1121-1125.
87. Kawamura R., Ikuta H., Fukuzumi S., Yamada R., Tsubaki S., Kodama T., et al. Intoxication by manganese in well water. Kitasato Arch. Exp. Med. 1941, 18:145-169.
88. Keen C.L., Clegg M.S., Lonnerdal B., Hurley L.S. Whole-blood manganese as an indicator of body manganese. N Engl J Med 1983, 308:1230.
89. Keen C.L., Ensunsa J.L., Watson M.H., Baly D.L., Donovan S.M., Monaco M.H., et al. Nutritional aspects of manganese from experimental studies. Neurotoxicology 1999, 20:213-223.
90. Kemmerer A., Elvehjem C., Hart E. Studies on the relation of manganese to the nutrition of the mouse. J Biol Chem 1931, 92:623-630.
91. Kim Y. High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese. Ind Health 2004, 42:111-115.
92. Kivivuori S.M., Pelkonen P., Ylijoki H., Verronen P., Siimes M.A. Elevated serum transferrin receptor concentration in children with juvenile chronic arthritis as evidence of iron deficiency. Rheumatology (Oxford) 2000, 39:193-197.
93. Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN). J Pediatr Gastroenterol Nutr 2005, 41(Suppl 2):S1-S87.
94. Komaki H., Maisawa S., Sugai K., Kobayashi Y., Hashimoto T. Tremor and seizures associated with chronic manganese intoxication. Brain Dev 1999, 21:122-124.
95. Kondakis X.G., Makris N., Leotsinidis M., Prinou M., Papapetropoulos T. Possible health effects of high manganese concentration in drinking water. Arch Environ Health 1989, 44:175-178.
96. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 2009, 89:535-606.
97. Laohaudomchok W., Lin X., Herrick R.F., Fang S.C., Cavallari J.M., Shrairman R., et al. Neuropsychological effects of low-level manganese exposure in welders. Neurotoxicology 2011, 32:171-179.
98. Lipe G.W., Duhart H., Newport G.D., Slikker W., Ali S.F. Effect of manganese on the concentration of amino acids in different regions of the rat brain. J Environ Sci Health B 1999, 34:119-132.
99. Lucchini R., Selis L., Folli D., Apostoli P., Mutti A., Vanoni O., et al. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health 1995, 21:143-149.
100. Malecki E.A., Radzanowski G.M., Radzanowski T.J., Gallaher D.D., Greger J.L. Biliary manganese excretion in conscious rats is affected by acute and chronic manganese intake but not by dietary fat. J Nutr 1996, 126:489-498.
101. Masumoto K., Suita S., Taguchi T., Yamanouchi T., Nagano M., Ogita K., et al. Manganese intoxication during intermittent parenteral nutrition: report of two cases. J Parenter Enter Nutr 2001, 25:95-99.
102. McKinney A.M., Filice R.W., Teksam M., Casey S., Truwit C., Clark H.B., et al. Diffusion abnormalities of the globi pallidi in manganese neurotoxicity. Neuroradiology 2004, 46:291-295.
103. Mehta R., Reilly J.J. Manganese levels in a jaundiced long-term total parenteral nutrition patient: potentiation of haloperidol toxicity? Case report and literature review. J Parenter Enter Nutr 1990, 14:428-430.
104. Mergler D., Baldwin M. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 1997, 73:92-100.
105. Mergler D., Baldwin M., Belanger S., Larribe F., Beuter A., Bowler R., et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology 1999, 20:327-342.
106. Milne D.B., Sims R.L., Ralston N.V. Manganese content of the cellular components of blood. Clin Chem 1990, 36:450-452.
107. Mirowitz S.A., Westrich T.J. Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 1992, 185:535-536.
108. Mirowitz S.A., Westrich T.J., Hirsch J.D. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 1991, 181:117-120.
109. Mirtallo J., Canada T., Johnson D., Kumpf V., Petersen C., Sacks G., et al. Safe practices for parenteral nutrition. J Parenter Enter Nutr 2004, 28:S39-S70.
110. Montes S., Riojas-Rodriguez H., Sabido-Pedraza E., Rios C. Biomarkers of manganese exposure in a population living close to a mine and mineral processing plant in Mexico. Environ Res 2008, 106:89-95.
111. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 1999, 162:102-105.
112. Nance P. Reference dose (RfD). Encyclopedia of toxycology 2005, 633-634. Elsevier Inc.
113. Ono J., Harada K., Kodaka R., Sakurai K., Tajiri H., Takagi Y., et al. Manganese deposition in the brain during long-term total parenteral nutrition. J Parenter Enter Nutr 1995, 19:310-312.
114. Pierro A., Carnielli V., Filler R.M., Smith J., Heim T. Metabolism of intravenous fat emulsion in the surgical newborn. J Pediatr Surg 1989, 24:95-101.
115. Pivac N., Knezevic J., Mustapic M., Dezeljin M., Muck-Seler D., Kozaric-Kovacic D., et al. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men. Life Sci 2006, 79:45-49.
116. Punnonen K., Irjala K., Rajamaki A. Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 1994, 40:774-776.
117. Reimund J.M., Dietemann J.L., Warter J.M., Baumann R., Duclos B. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition. Clin Nutr 2000, 19:343-348.
118. Reynolds A.P., Kiely E., Meadows N. Manganese in long term paediatric parenteral nutrition. Arch Dis Child 1994, 71:527-528.
119. Roels H., Lauwerys R., Genet P., Sarhan M.J., de Fays M., Hanotiau I., et al. Relationship between external and internal parameters of exposure to manganese in workers from a manganese oxide and salt producing plant. Am J Ind Med 1987, 11:297-305.
120. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 1992, 49:25-34.
121. Rouault T.A., Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 2006, 13:142-148.
122. Saitoh Y., Kimura S., Nezu A., Ohtsuki N., Kobayashi T., Osaka H., et al. Hyperintense brain lesions on T1-weighted MRI after parenteral nutrition. No To Hattatsu Brain Dev 1996, 28:39-43.
123. Santamaria A.B., Sulsky S.I. Risk assessment of an essential element: manganese. J Toxicol Environ Health A 2010, 73:128-155.
124. Santos D., Batoreu M.C., Almeida I., Ramos R., Sidoryk-Wegrzynowicz M., Aschner M., et al. Manganese Alters Rat Brain Amino Acids Levels. Biol Trace Elem Res 2012, 150:337-341.
125. Sax H.C., Talamini M.A., Brackett K., Fischer J.E. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery 1986, 100:697-704.
126. Shattuck K.E., Grinnell C.D., Rassin D.K. Amino acid infusions induce reversible, dose-related decreases in bile flow in the isolated rat liver. J Parenter Enter Nutr 1993, 17:171-176.
127. Shukla G.S., Chandra S.V., Seth P.K. Effect of manganese on the levels of DNA, RNA, DNase and RNase in cerebrum, cerebellum and rest of brain regions of rat. Acta Pharmacol Toxicol (Copenh) 1976, 39:562-569.
128. Siepler J.K., Nishikawa R.A., Diamantidis T., Okamoto R. Asymptomatic hypermanganesemia in long-term home parenteral nutrition patients. Nutr Clin Pract 2003, 18:370-373.
129. Silbergeld E.K., Davis D.L. Role of biomarkers in identifying and understanding environmentally induced disease. Clin Chem 1994, 40:1363-1367.
130. Sinczuk-Walczak H., Jakubowski M., Matczak W. Neurological and neurophysiological examinations of workers occupationally exposed to manganese. Int J Occup Med Environ Health 2001, 14:329-337.
131. Siqueira M.E., Moraes E.C. Homovanillic acid (HVA) and manganese in urine of workers exposed in a ferromanganese alloy plant. Med Lav 1989, 80:224-228.
132. Sloot W.N., Gramsbergen J.B. Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 1994, 657:124-132.
133. Smargiassi A., Mutti A. Peripheral biomarkers and exposure to manganese. Neurotoxicology 1999, 20:401-406.
134. Smargiassi A., Mergler D., Bergamaschi E., Vettori M.V., Lucchini R., Apostoli P. Peripheral markers of catecholamine metabolism among workers occupationally exposed to manganese (Mn). Toxicol Lett 1995, 77:329-333.
135. Stanwood G.D., Leitch D.B., Savchenko V., Wu J., Fitsanakis V.A., Anderson D.J., et al. Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. J Neurochem 2009, 110:378-389.
136. Takagi Y., Okada A., Sando K., Wasa M., Yoshida H., Hirabuki N. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am J Clin Nutr 2002, 75:112-118.
137. Takeda A., Ishiwatari S., Okada S. In vivo stimulation-induced release of manganese in rat amygdala. Brain Res 1998, 811:147-151.
138. Takser L., Mergler D., de Grosbois S., Smargiassi A., Lafond J. Blood manganese content at birth and cord serum prolactin levels. Neurotoxicol Teratol 2004, 26:811-815.
139. Taylor S., Manara A.R. Manganese toxicity in a patient with cholestasis receiving total parenteral nutrition. Anaesthesia 1994, 49:1013.
140. Thompson K., Molina R.M., Donaghey T., Schwob J.E., Brain J.D., Wessling-Resnick M. Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J 2007, 21:223-230.
141. Tuschl K., Clayton P.T., Gospe S.M., Samshad G., Ibrahim S., Singhi P., et al. The first inborn error of manganese metabolism caused by mutations in SLC30A10, a newly identified manganese transporter. The Lancet 2013, 381:S110.
142. Underwood E.J. The incidence of trace element deficiency diseases. Philos Trans R Soc Lond B: Biol Sci 1981, 294:3-8.
143. US EPA. Manganese (CASRN 7439-96-5). US Environmental Protection Agency; 1996.
144. Wang X., Li G.J., Zheng W. Upregulation of DMT1 expression in choroidal epithelia of the blood-CSF barrier following manganese exposure in vitro. Brain Res 2006, 1097:1-10.
145. Wasserman G.A., Liu X., Parvez F., Ahsan H., Levy D., Factor-Litvak P., et al. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 2006, 114:124-129.
146. Wasserman G.A., Liu X., Parvez F., Factor-Litvak P., Ahsan H., Levy D., et al. Arsenic and manganese exposure and children's intellectual function. Neurotoxicology 2011, 32:450-457.
147. Weed R.I., Rothstein A. The uptake of divalent manganese ion by mature normal human red blood cells. J Gen Physiol 1960, 44:301-314.
148. WHO Principles for evaluating health risks in children associated with exposure to chemicals World Health Organization. Environ Health Criteria 2006, 237:1-329.
149. Witzleben C., Pitlick P., Bergmeyer J. Acute manganese overload: a new experimental model of intrahepatic cholestasis. Am J Pathol 1968, 53:409-423.
150. Wretlind A. Complete intravenous nutrition. Theoretical and experimental background. Nutr Metab 1972, 14:1S-57S.
151. Zheng W., Fu S.X., Dydak U., Cowan D.M. Biomarkers of manganese intoxication. Neurotoxicology 2011, 32:1-8.
152. Zielhuis R.L. Recent and potential advances applicable to the protection of workers' health-biological monitoring. Assessment of toxic agents at the workplace-roles of ambient and biological monitoring 1984, 84-94. Martinus Nijhoff Publishers, Boston. A. Berlin, R.E. Yodaiken, B.A. Henman (Eds.).